What is GoodRx Holdings, Inc.'s market cap?

GoodRx Holdings, Inc. (GDRX) has a market capitalization of $1.0B and trades on NASDAQ.

What is GoodRx Holdings, Inc.'s revenue and profitability?

GoodRx Holdings, Inc. generated $787.9M in trailing twelve-month revenue with net income of $20.6M, representing a net margin of 2.6%. Gross margin stands at 91.8%, with free cash flow of $165.8M. These figures are based on the Q1 2026 filing.

Who are GoodRx Holdings, Inc.'s competitors?

GoodRx Holdings, Inc.'s key competitors include CVS Health, Amazon, BrightSpring Health Services, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does GoodRx Holdings, Inc. partner with?

GoodRx Holdings, Inc.'s notable partners include Kroger, TrumpRx.

What subsidiaries does GoodRx Holdings, Inc. have?

GoodRx Holdings, Inc.'s subsidiaries include GoodRx, Inc..

Where is GoodRx Holdings, Inc. headquartered?

GoodRx Holdings, Inc. is headquartered in United States of America and employs approximately 694 people. It has been publicly traded since 2020.

GoodRx Holdings, Inc.

GDRX

GoodRx Holdings, Inc. operates a leading consumer-focused digital healthcare platform in the United States designed to improve price transparency and affordability for prescription medications.

Market cap

$1.03B-40.9%

Revenue$787.9M-1.2%

Net income$20.6M-27.8%

Free cash flow$165.8M+10.7%

EPS (diluted)$0.06-25.0%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 6, 2026

Revenue$194.0MBeat by $8.6M EPS$0.07In line

Read the full report

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$193.2M

EPS estimate$0.08

Financials

Q1 2026

Income statement

See full

Revenue$194.0M-4.4%

Gross profit$173.9M-8.3%

Operating income$14.0M-40.1%

Net income$1.2M-89.4%

EPS (diluted)$0.00-100%

Balance sheet

See full

Cash & equivalents$235.7M-21.7%

Total debt$541.4M0.0%

Total equity$622.0M-4.9%

Total assets$2.0B+56.0%

Cash flow

See full

Operating cash flow$11.8M+25.8%

CapEx$1.1M+700%

Free cash flow$10.7M+15.4%

Valuation & ratios

Valuation

See full

Market cap$1.03B-40.9%

Enterprise value$1.34B-34.9%

P/E50.3×-1.5×

P/S1.3×-0.9×

Profitability

See full

Gross margin91.8%-2.0pp

Operating margin9.9%-0.3pp

Net margin2.6%-1.0pp

FCF margin21%+2.3pp

Returns & leverage

See full

Return on equity3.2%-1.2pp

Debt / equity0.9×0.0×

Current ratio1.5×-3.8×

Segments

By product

See full

Prescription transactions revenue$113.7M-23.7%

Pharma Direct revenue$52.2M+82.3%

Subscription revenue$24.4M+16.1%

Other revenue$3.7M-15.8%

Competitors

By market cap

Amazon$2.49T+0.7%

CVS Health$136.61B+81.1%

Cencora$60.5B+9.1%

BrightSpring Health Services, Inc.$14.1B+292%

Amneal Pharmaceuticals, Inc.$5.8B+126%

Doximity$3.8B-67.0%

GoodRx Holdings, Inc.$1.0B-42.3%

Sunshine Biopharma$245.8K-96.5%

By revenue growth

BrightSpring Health Services, Inc.+28.0%

Amazon+14.2%

Doximity+13.1%

CVS Health+7.6%

Amneal Pharmaceuticals, Inc.+7.6%

Cencora+5.9%

GoodRx Holdings, Inc.-1.2%

By net margin

Doximity30.4%-8.7pp

Amazon10.65%+0.5pp

Amneal Pharmaceuticals, Inc.4.01%+4.5pp

GoodRx Holdings, Inc.2.61%-1.0pp

BrightSpring Health Services, Inc.2.27%+2.3pp

CVS Health0.719%-0.7pp

Cencora0.599%+0.6pp

Profile

GoodRx Holdings, Inc. operates a leading consumer-focused digital healthcare platform in the United States designed to improve price transparency and affordability for prescription medications. The company aggregates and normalizes billions of pricing data points to provide consumers with geographically relevant discounts and negotiated prices. Its platform serves as an essential access layer connecting consumers, healthcare providers, pharmacies, and pharmaceutical manufacturers to drive better health outcomes and medication adherence.

Competitive position

A leading price transparency platform with a massive proprietary database of over 420 billion daily pricing data points and deep integrations across the PBM and pharmacy ecosystem.

GeographiesUnited States

Customer segmentsConsumers, Healthcare Providers, Pharmaceutical Companies

Business modelMarketplace, Subscription, Advertising, B2B2C

SuppliersPharmacy Benefit Managers (PBMs), Pharmaceutical manufacturers, Cloud infrastructure providers, Electronic Health Record (EHR) vendors

CustomersRetail pharmacies, Individual consumers, Healthcare professionals, Self-insured employers

CountryUnited States of America

Listed2020

Employees694.0

CEOWendy Barnes

SectorHealthcare

IndustryMedical - Healthcare Information Services

Websitegoodrx.com

FilingsSEC EDGAR

Ask your AI about GoodRx Holdings, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s market cap?: GoodRx Holdings, Inc. (GDRX) has a market capitalization of $1.0B and trades on NASDAQ.
What is GoodRx Holdings, Inc.'s revenue and profitability?: GoodRx Holdings, Inc. generated $787.9M in trailing twelve-month revenue with net income of $20.6M, representing a net margin of 2.6%. Gross margin stands at 91.8%, with free cash flow of $165.8M. These figures are based on the Q1 2026 filing.
Who are GoodRx Holdings, Inc.'s competitors?: GoodRx Holdings, Inc.'s key competitors include CVS Health, Amazon, BrightSpring Health Services, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does GoodRx Holdings, Inc. partner with?: GoodRx Holdings, Inc.'s notable partners include Kroger, TrumpRx.
What subsidiaries does GoodRx Holdings, Inc. have?: GoodRx Holdings, Inc.'s subsidiaries include GoodRx, Inc..
Where is GoodRx Holdings, Inc. headquartered?: GoodRx Holdings, Inc. is headquartered in United States of America and employs approximately 694 people. It has been publicly traded since 2020.